Zuoyun Wang | Biology | Best Researcher Award

Published on by China Scientist

Dr. Zuoyun Wang | Biology | Best Researcher Award

Dr. Zuoyun Wang is a professor in the Department of Anatomy and Embryology at the School of Basic Medicine, Fudan University, and a doctoral supervisor. She obtained her PhD in Cell Biology from the Chinese Academy of Sciences. Her research focuses on the Hippo signaling pathway in tissue regeneration and tumorigenesis, using organoids, mouse models, and clinical samples. Dr. Wang has published over 30 papers in high-impact journals and has received multiple honors, including the Shanghai Oriental Talent award and the Excellent Youth Talent Award from the Chinese Academy of Sciences.

Dr. Zuoyun Wang | Fudan University | China

Profile

SCOPUS ID

ORCID ID

Education

  • Dr. Zuoyun Wang earned her PhD in Cell Biology from the Institute of Biochemistry and Cell Biology at the Shanghai Institute for Biological Sciences, Chinese Academy of Sciences. Her academic training laid a solid foundation in the cellular and molecular mechanisms that regulate tissue development and disease processes.

Experience

  • Dr. Wang currently serves as a professor in the Department of Anatomy and Embryology at the School of Basic Medicine, Fudan University. She leads a dynamic research group and also serves as a doctoral supervisor, guiding the next generation of biomedical scientists. Her role includes both teaching and conducting cutting-edge research in cellular biology and tissue regeneration.

Awards and Recognition

  • Throughout her career, Dr. Wang has been recognized with numerous prestigious honors. These include the Shanghai Oriental Talent award, the Excellent Youth Talent Award and the Sanofi Excellent Youth Talent Award from the Chinese Academy of Sciences. She also received the Outstanding Youth Scholar Award from the Shanghai Society for Cell Biology and won first prize in the Shanghai University Teacher Innovation Competition, reflecting her excellence in both research and academic leadership.

Skills and Certifications

  • Dr. Wang possesses advanced expertise in molecular and cellular biology, particularly in relation to the Hippo signaling pathway. She is skilled in the use of organoids, genetically engineered mouse models, and the analysis of clinical tissue samples. Her approach integrates basic science and translational research, bridging the gap between laboratory findings and clinical applications.

Research Focus

  • The central focus of Dr. Wang’s research lies in the Hippo signaling pathway and its role in tissue regeneration and tumorigenesis. Her group investigates how this pathway contributes to maintaining tissue homeostasis and how its dysregulation may lead to disease. Using a combination of organoid cultures, animal models, and patient-derived samples, her work aims to uncover novel mechanisms and therapeutic targets for related diseases and cancers.

Conclusion

  • Dr. Zuoyun Wang is a leading biomedical scientist whose contributions have significantly advanced the understanding of tissue regeneration and cancer biology. Through her leadership, innovative research, and academic mentorship, she continues to influence the field of cell biology and provide valuable insights into disease diagnosis and therapy.

Publications

  • The Hippo Signaling Pathway Modulates Pancreatic Tissue Homeostasis
    Authors: Wang, X.; Du, J.; Li, H.; Cao, Z.; Cheng, Z.; Wang, Z.
    Journal: Cell Death Discovery

  • The Hippo Signalling Pathway in Bone Homeostasis: Under the Regulation of Mechanics and Aging
    Authors: Li, Z.; Lin, J.; Wu, J.; Suo, J.; Wang, Z.
    Journal: Cell Proliferation

  • DNA Bridging of FOXP3 Ladder-Like Multimer: Unveiling a Novel Transcriptional Regulation Paradigm
    Authors: Lu, Y.; Li, L.; Yang, H.; Li, B.; Wang, Z.
    Journal: The Innovation

  • MST1/2: Important Regulators of Hippo Pathway in Immune System Associated Diseases
    Authors: Zhou, J.; Li, L.; Wu, B.; Feng, Z.; Lu, Y.; Wang, Z.
    Journal: Cancer Letters

  • ASB3 Promotes Hepatocellular Carcinoma Progression by Mediating DR5 Ubiquitination in TRAIL Resistance
    Authors: Huang, L.; Che, Z.; Liu, F.; Ge, M.; Wu, Z.; Wu, L.; Chen, W.; Wang, Z.; Zhu, Z.; Xu, W. et al.
    Journal: The FASEB Journal

Prof Dr. Daling Zhu | Genetics and Molecular Biology | Best Researcher Award | 1164

Published on by China Scientist

Prof Dr. Daling Zhu | Genetics and Molecular Biology | Best Researcher Award

Prof Dr. Daling Zhu, Harbin Medical University, China

 Profile

Scopus

OrcID

📚 Early Academic Pursuits

Professor Daling Zhu is an eminent scholar with a profound background in medical research and academia. He has a distinguished career beginning with his appointment as a PhD Supervisor and Postdoctoral Cooperative Supervisor.

💼 Professional Endeavors

Daling Zhu holds several prestigious titles, including the first batch of “Longjiang Scholars” distinguished professors. He has been recognized as an expert with special allowances from both national and Heilongjiang provincial governments and has been acknowledged as an outstanding middle-aged and young expert in Heilongjiang Province. He has held notable positions such as the Director of the Department of Pharmacy at the Second Affiliated Hospital of Harbin Medical University, Dean of the School of Pharmacy, and President of the Daqing Campus.

🔬CONTRIBUTIONS AND RESEARCH FOCUS

  • Professor Daling Zhu has significantly contributed to the field of pulmonary hypertension through his extensive research efforts. He has successfully undertaken and completed 35 scientific research projects, including a major research project of the National Natural Science Foundation of China, the National Natural Science Foundation of China Foreign Exchange and Cooperation Project, sub-projects of the “863” project, and the National Science and Technology Research Program (973) – sub-project of the China Human Liver Proteome Program. Additionally, he has led a project for the American College of Cardiology and various major provincial and municipal projects. His research has earned him numerous accolades, including second prizes for outstanding achievements in scientific research from the Ministry of Education and a first prize for natural science from the Heilongjiang Provincial Government. These contributions have advanced the understanding and treatment of pulmonary hypertension, highlighting Professor Zhu’s role as a leading figure in medical research.

🌟Impact and Influence

  • Professor Daling Zhu’s work has had a profound impact on the field of pulmonary hypertension and beyond. His extensive research has led to critical advancements in understanding the molecular mechanisms of this condition, resulting in improved early diagnosis and treatment strategies. The recognition of his contributions is evident through numerous prestigious awards, including second prizes for outstanding scientific research achievements from the Ministry of Education and a first prize for natural science from the Heilongjiang Provincial Government. With 167 SCI-indexed articles published in prominent foreign academic journals, his research has gained significant global recognition, influencing peers and guiding future studies in the field. Professor Zhu’s contributions continue to shape the landscape of medical research, making a lasting impact on both the scientific community and patient care.

🔬 RESEARCH FOCUS

Professor Zhu is primarily engaged in research on the pathogenesis of pulmonary hypertension and the identification of early diagnosis and treatment targets. His work has significantly advanced the understanding of molecular mechanisms underlying this condition.

📖 ACADEMIC CITES

Professor Zhu has published 167 SCI-indexed articles in foreign academic journals, demonstrating his prolific contribution to scientific literature and his research’s global impact.

🌍 LEGACY AND FUTURE CONTRIBUTIONS

Through his extensive research and numerous publications, Professor Zhu has cemented his legacy in the scientific community. His future contributions will continue to influence the field of pulmonary hypertension, providing critical insights and advancements in diagnosis and treatment.

📰PUBLICATIONS

    • 1. SP1 undergoes phase separation and activates RGS20 expression through super-enhancers to promote lung adenocarcinoma progression

      • Authors: Shan, L., Wang, W., Du, L., Sui, G., Liu, F.
      • Journal: Proceedings of the National Academy of Sciences of the United States of America, 2024, 121(29), e2401834121

      2. Presenilin 1 Is a Therapeutic Target in Pulmonary Hypertension and Promotes Vascular Remodeling

      • Authors: Shen, T., Shi, J., Zhao, X., Liu, P., Zhu, D.
      • Journal: American Journal of Respiratory Cell and Molecular Biology, 2024, 70(6), pp. 468–481

      3.Super enhancer-associated circRNA-circLrch3 regulates hypoxia-induced pulmonary arterial smooth muscle cells pyroptosis by formation of R-loop with host gene

        • Authors: Liu, H., Jiang, Y., Shi, R., Zheng, X., Zhu, D.
        • Journal: International Journal of Biological Macromolecules, 2024, 268, 130853

      4. Erratum: lnc-Rps4l-encoded peptide RPS4XL regulates RPS6 phosphorylation and inhibits the proliferation of PASMCs caused by hypoxia (Molecular Therapy (2021) 29(4) (1411–1424), (S1525001621000058), (10.1016/j.ymthe.2021.01.005))

      • Authors: Li, Y., Zhang, J., Sun, H., Shi, W., Zhu, D.
      • Journal: Molecular Therapy, 2024

      5. Super Enhancer-Associated Circular RNA-CircKrt4 Regulates Hypoxic Pulmonary Artery Endothelial Cell Dysfunction in Mice

      • Authors: Ma, C., Wang, X., Zhang, L., Qu, L., Zhu, D.
      • Journal: Arteriosclerosis, Thrombosis, and Vascular Biology, 2023, 43(7), pp. 1179–1198